BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36288948)

  • 21. College of American Pathologists Tumor Regression Grading System for Long-Term Outcome in Patients with Locally Advanced Rectal Cancer.
    Chen HY; Feng LL; Li M; Ju HQ; Ding Y; Lan M; Song SM; Han WD; Yu L; Wei MB; Pang XL; He F; Liu S; Zheng J; Ma Y; Lin CY; Lan P; Huang MJ; Zou YF; Yang ZL; Wang T; Lang JY; Orangio GR; Poylin V; Ajani JA; Wang WH; Wan XB
    Oncologist; 2021 May; 26(5):e780-e793. PubMed ID: 33543577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical analysis for therapeutic targets and prognostic markers in low-grade endometrial stromal sarcoma.
    Park JY; Kim KR; Nam JH
    Int J Gynecol Cancer; 2013 Jan; 23(1):81-9. PubMed ID: 23221606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synovial sarcoma of children and adolescents: the prognostic role of axial sites.
    Ferrari A; Bisogno G; Alaggio R; Cecchetto G; Collini P; Rosolen A; Meazza C; Indolfi P; Garaventa A; De Sio L; D'Angelo P; Tamaro P; Casanova M; Carli M
    Eur J Cancer; 2008 Jun; 44(9):1202-9. PubMed ID: 18440800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression.
    ten Heuvel SE; Hoekstra HJ; Bastiaannet E; Suurmeijer AJ
    Appl Immunohistochem Mol Morphol; 2009 May; 17(3):189-95. PubMed ID: 18997619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New perspectives for staging and prognosis in soft tissue sarcoma.
    Lahat G; Tuvin D; Wei C; Anaya DA; Bekele BN; Lazar AJ; Pisters PW; Lev D; Pollock RE
    Ann Surg Oncol; 2008 Oct; 15(10):2739-48. PubMed ID: 18521685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modified staging system for extremity soft tissue sarcomas.
    Ramanathan RC; A'Hern R; Fisher C; Thomas JM
    Ann Surg Oncol; 1999; 6(1):57-69. PubMed ID: 10030416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors in localized primary synovial sarcoma: a multicenter study of 128 adult patients.
    Trassard M; Le Doussal V; Hacène K; Terrier P; Ranchère D; Guillou L; Fiche M; Collin F; Vilain MO; Bertrand G; Jacquemier J; Sastre-Garau X; Bui NB; Bonichon F; Coindre JM
    J Clin Oncol; 2001 Jan; 19(2):525-34. PubMed ID: 11208847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular and immunohistochemical analysis of the prognostic value of cell-cycle regulators in urothelial neoplasms of the bladder.
    Yurakh AO; Ramos D; Calabuig-Fariñas S; López-Guerrero JA; Rubio J; Solsona E; Romanenko AM; Vozianov AF; Pellin A; Llombart-Bosch A
    Eur Urol; 2006 Sep; 50(3):506-15; discussion 515. PubMed ID: 16624482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of expression of cancer stem cell markers and fusion gene in synovial sarcoma: Insights into histogenesis and pathogenesis.
    Zhou Y; Chen D; Qi Y; Liu R; Li S; Zou H; Lan J; Ju X; Jiang J; Liang W; Shen Y; Pang L; Li F
    Oncol Rep; 2017 Jun; 37(6):3351-3360. PubMed ID: 28498445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histology and grading are important prognostic factors in synovial sarcoma.
    Bianchi G; Sambri A; Righi A; Dei Tos AP; Picci P; Donati D
    Eur J Surg Oncol; 2017 Sep; 43(9):1733-1739. PubMed ID: 28579008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of p16, p53, and pcna in sarcoma and an evaluation of immune infiltration.
    Cai D; Ma X; Guo H; Zhang H; Bian A; Yu H; Cheng W
    J Orthop Surg Res; 2022 Jun; 17(1):305. PubMed ID: 35689249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.
    Levesque MA; Katsaros D; Massobrio M; Genta F; Yu H; Richiardi G; Fracchioli S; Durando A; Arisio R; Diamandis EP
    Clin Cancer Res; 2000 Aug; 6(8):3260-70. PubMed ID: 10955812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined cytoplasmic and membranous EGFR and p53 overexpression is a poor prognostic marker in early stage oral squamous cell carcinoma.
    Monteiro LS; Diniz-Freitas M; Garcia-Caballero T; Warnakulasuriya S; Forteza J; Fraga M
    J Oral Pathol Med; 2012 Aug; 41(7):559-67. PubMed ID: 22417132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression and prognostic value of COX- 2, p16(INK4A) and p53 in patients with classical Hodgkin lymphoma].
    Shi Y; Gao Z; Liu C; Huang X; Song Y; Ping L; Zhou L; Zhao M; Huang X; Lai Y; Du T; Li M
    Zhonghua Xue Ye Xue Za Zhi; 2015 Nov; 36(11):926-32. PubMed ID: 26632465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic implication of SYT-SSX fusion type and clinicopathological parameters for tumor-related death, recurrence, and metastasis in synovial sarcoma.
    Sun Y; Sun B; Wang J; Cai W; Zhao X; Zhang S; Hao X
    Cancer Sci; 2009 Jun; 100(6):1018-25. PubMed ID: 19385976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synovial sarcoma: the importance of size and location for survival.
    Deshmukh R; Mankin HJ; Singer S
    Clin Orthop Relat Res; 2004 Feb; (419):155-61. PubMed ID: 15021147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1.
    Iura K; Maekawa A; Kohashi K; Ishii T; Bekki H; Otsuka H; Yamada Y; Yamamoto H; Harimaya K; Iwamoto Y; Oda Y
    Hum Pathol; 2017 Mar; 61():130-139. PubMed ID: 27993576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma.
    He MM; Zhang DS; Wang F; Wang ZQ; Luo HY; Ren C; Jin Y; Chen DL; Xu RH
    World J Gastroenterol; 2014 Jan; 20(1):264-73. PubMed ID: 24415881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new prognostic model comprising p53, EGFR, and tumor grade in early stage epithelial ovarian carcinoma and avoiding the problem of inaccurate surgical staging.
    Skírnisdóttir I; Seidal T; Sorbe B
    Int J Gynecol Cancer; 2004; 14(2):259-70. PubMed ID: 15086725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of bcl-2, c-myc, survivin and tumor grade in synovial sarcoma.
    Demır D; Yaman B; Anacak Y; Keçecı B; Kandıloğlu G; Akalin T
    Turk Patoloji Derg; 2014; 30(1):55-65. PubMed ID: 24448706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.